Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Vioxx Is Lowest-Priced COX-2 Through Medicare Card Program

Executive Summary

Merck is positioning Vioxx as the lowest-cost COX-2 inhibitor through the Medicare drug discount card program

You may also be interested in...



Medicare Rx Cards May Negatively Affect Manufacturer Profits – McClellan

Medicare drug card discounts and transparent drug prices could negatively affect pharmaceutical manufacturers' profits in certain drug classes, CMS Administrator McClellan told a press briefing May 5

Drug Card Price Complexity Is CMS Learning Experience, Consultant Says

The Centers for Medicare & Medicaid Services' experience dealing with the complexity of prescription drug pricing through the Medicare discount card program is a valuable learning experience as the agency works on regulations for the Part D benefit, Health Strategies Consultancy President Dan Mendelson said

Medicare Rx Cards May Negatively Affect Manufacturer Profits – McClellan

Medicare drug card discounts and transparent drug prices could negatively affect pharmaceutical manufacturers' profits in certain drug classes, CMS Administrator McClellan told a press briefing May 5

Related Content

UsernamePublicRestriction

Register

PS043937

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel